大血藤与败酱草乙酸乙酯提取物通过调控巨噬细胞极化缓解盆腔炎
本研究探讨大血藤与败酱草(S&P)抗盆腔炎(PID)的药效成分及机制。采用CCK-8与NO抑制实验筛选出乙酸乙酯(EtOAc)提取物为最有效组分,并在LPS诱导的PID小鼠模型及巨噬细胞中验证。结果表明EtOAc提取物通过抑制HK-II介导的糖酵解及NF-κB通路,平衡巨噬细胞极化,从而缓解PID。
要点
- S&P的EtOAc提取物是抗PID主要活性组分
- EtOAc提取物促进巨噬细胞向M2表型极化
- 机制涉及抑制HK-II介导的糖酵解和NF-κB通路
核心结论
- 大血藤与败酱草EtOAc提取物通过抑制HK-II介导的糖酵解和NF-κB轴,平衡巨噬细胞极化,从而缓解LPS诱导的盆腔炎。
研究设计与样本
- 采用CCK-8和NO抑制实验从EtOAc、正丁醇和水三种溶剂萃取部位中筛选最佳提取物。
- 使用LPS诱导的PID小鼠模型评估EtOAc提取物对子宫组织病理学和巨噬细胞表型的影响。
- 利用RNA测序分析EtOAc提取物处理后的差异表达基因,并通过流式细胞术检测细胞因子和巨噬细胞表型标志物。
- 采用基于LC-MS/MS的代谢分析和蛋白质印迹研究潜在机制。
主要发现
- EtOAc提取物抑制iNOS介导的NO产生且无细胞毒性,抑制IL-6释放并上调M2标志物CD206。
- 在PID小鼠模型中,EtOAc提取物减轻LPS诱导的盆腔炎症,减少子宫F4/80+和CD86+(M1)巨噬细胞,上调CD206+(M2)亚群。
- 子宫组织转录组显示EtOAc提取物上调M2极化、组织修复、血管重塑、子宫内膜容受性和乳酸代谢相关基因,下调M1巨噬细胞、炎症及糖酵解和乳酸合成相关基因。
- 代谢组学显示EtOAc提取物改善LPS诱导的代谢紊乱,差异代谢物涉及TCA循环、精氨酸和脯氨酸代谢、丙酮酸代谢及糖酵解或糖异生通路。
- EtOAc提取物抑制糖代谢关键蛋白HKI、HKII、PKM2和PD表达,抑制NF-κB和IκB-α磷酸化,并与HK-II抑制剂2-脱氧-D-葡萄糖协同。
关键数值与推荐
- EtOAc提取物为三种溶剂萃取部位中最有效组分,可抑制iNOS介导的NO产生且无细胞毒性。
- EtOAc提取物在LPS诱导的RAW264.7和THP-1细胞中抑制IL-6释放并上调CD206。
- 在LPS诱导的PID小鼠模型中,EtOAc提取物减少子宫F4/80+和CD86+巨噬细胞,上调CD206+亚群。
- EtOAc提取物抑制HKI、HKII、PKM2和PD表达及NF-κB和IκB-α磷酸化,与2-脱氧-D-葡萄糖协同。
临床怎么用
- 大血藤与败酱草EtOAc提取物可能作为PID的植物治疗候选,其机制涉及巨噬细胞免疫代谢重编程。
- 临床可关注调控巨噬细胞M1/M2极化平衡及HK-II介导糖酵解作为PID治疗策略。
- EtOAc提取物与HK-II抑制剂联用可能具有协同抗炎潜力。
局限性
- 研究仅基于LPS诱导的小鼠模型和细胞实验,尚未提供人体临床试验数据。
- EtOAc提取物为混合物,其具体活性成分尚未完全明确。
- 机制研究主要集中于HK-II/NF-κB轴,其他潜在通路未全面探讨。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pelvic inflammatory disease (PID) is a prevalent gynecological infection, that poses significant therapeutic challenges. Sargentodoxa cuneata and Patrinia villosa (S&P) demonstrate empirical efficacy in PID treatment within traditional Chinese medicine practice. However, their active components and precise anti-inflammatory mechanisms should be systematically elucidated. PURPOSE: This study aimed to investigate the pharmacologically active components of S&P and decipher their anti-inflammatory mechanism through integrated multi-omics approaches. MATERIALS AND METHODS: CCK-8 and NO inhibition assays were used to screen the optimal extract from three solvent partitions (ethyl acetate [EtOAc], n-butanol [n-BuOH], and water). The chemical components of different extracts and S&P were detected by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS). The effects of EtOAc extract on PID were studied in an lipopolysaccharide (LPS) -induced PID murine model to evaluate uterine histopathology and macrophage phenotype. RNA sequencing was utilized to analyze the differentially expressed genes after EtOAc extract treatment. Cytokines and macrophage phenotype markers were detected by flow cytometry. LC-MS/MS-based metabolic analysis and western blotting were used to study the potential mechanism. RESULTS: Bioactivity screening identified EtOAc extract as the most potent fraction, suppressing iNOS-mediated NO production without cytotoxicity. EtOAc extract inhibited the release of IL-6 and upregulated the M2 phenotypic marker CD206 in LPS induced RAW264.7 and THP-1 cells. In the murine PID model, EtOAc extract treatment alleviated LPS-induced pelvic inflammation, reduced uterine F4/80+ and CD86+ (M1) macrophages, and upregulated CD206+ (M2) subset. Transcriptomics of uterine tissue demonstrated that EtOAc extract upregulated genes related to M2 macrophages polarization, tissue repair and vascular remodeling, and endometrial receptivity and lactic acid metabolism, and downregulated genes involved in M1 macrophages, inflammation, and glycolysis and lactic acid synthesis. Metabolomics analysis showed that EtOAc extract ameliorated LPS-induced metabolic disorder. The differentially expressed metabolites were involved in the tricarboxylic acid (TCA) cycle, arginine and proline metabolism, pyruvate metabolism, and glycolysis or gluconeogenesis pathways. EtOAc extract inhibited the expression of glucose metabolism key proteins HKI, HKII, PKM2 and PD, and NF-κB and IκB-ɑ phosphorylation, and synergized with HK-II inhibitor (2-deoxy-D-glucose). CONCLUSIONS: EtOAc extract alleviates LPS-induced PID via a novel immunometabolic axis, namely, by suppressing HK-II-mediated glycolysis through the NF-κB axis and balancing macrophages polarization. The mechanistic elucidation of macrophage immunometabolic reprogramming by S&P provides a molecular basis for phytotherapy in PID management.
引用
- Yu Q, Shao P, Liu X, et al. Ethyl acetate extract of Sargentodoxa cuneata and Patrinia villosa alleviates pelvic inflammation by shifting macrophages polarization. Phytomedicine. 2025. PMID: 41061288. doi:10.1016/j.phymed.2025.157345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。